Fund Holdings — Prosight Management, LP

Total Portfolio Value
$249.08M
Total Bought
$66.06M
Total Sold
$149.33M
Net Transaction
-$83.28M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
SHATTUCK LABS(STTK)2,123,0002,782,797+659,7973,22719,8417.97%+16,614
MEIRAGTX HOLDINGS(MGTX)4,078,8044,050,714-28,09020,02728,43611.42%+8,409
GALAPAGOS ADR REP(LKFT)730,207827,294+97,08725,22933,63013.50%+8,401
MEDTRONIC(MDT)150,000220,000+70,00011,75418,1247.28%+6,370
ADC THERAPEUTICS(ADCT)5,402,0416,471,800+1,069,7594,84610,7434.31%+5,898
GALAPAGOS ADR REP0120,000+120,00004,8781.96%+4,878
ORTHOPEDIATRICS(KIDS)095,000+95,00003,0881.24%+3,088
PRIVIA HEALTH GROUP(PRVA)0132,158+132,15803,0441.22%+3,044
QUIDELORTHO(QDEL)85,000118,920+33,9206,2088,7643.52%+2,556
MURAL ONCOLOGY0418,505+418,50502,4780.99%+2,478
PROTHENA
SHS
126,202229,539+103,3376,0898,3413.35%+2,252
PROTHENA
CALL
053,500+53,50001,9440.78%+1,944
VERADIGM0180,000+180,00001,8880.76%+1,888
ORIC PHARMACEUTICALS(ORIC)0200,000+200,00001,8400.74%+1,840
NUVATION BIO CL A(NUVB)1,050,0002,050,000+1,000,0001,4073,0961.24%+1,689
SPYRE THERAPEUTICS(SYRE)055,000+55,00001,1840.48%+1,184
SHOCKWAVE MEDICAL05,000+5,00009530.38%+953
ERASCA(ERAS)264,710599,458+334,7485211,2770.51%+755
GRAPHITE BIO1,337,8261,351,939+14,1133,3183,5421.42%+224
ELUTIA INC(ELUT)25,5940-25,594370—-37
BARRETT BUSINESS SERVICES21,38713,000-8,3871,9301,5050.60%-425
ZYMEWORKS INC(ZYME)106,4050-106,4056750—-675
BIOMEA FUSION(BMEA)94,81742,991-51,8261,3056240.25%-680
UNIVERSAL HEALTH SERVICES CL B(UHS)40,89028,090-12,8005,1414,2821.72%-859
ORIC PHARMACEUTICALS(ORIC)2,579,8021,578,263-1,001,53915,60814,5205.83%-1,088
EVOLUS INC(EOLS)126,9820-126,9821,1610—-1,161
CHEMED CORP NEW(CHE)2,5000-2,5001,2990—-1,299
AGILON HEALTH INC(AGL)79,0760-79,0761,4040—-1,404
ALKERMES(ALKS)65,00015,000-50,0001,8214160.17%-1,405
ABCELLERA BIOLOGICS(ABCL)2,446,0001,700,000-746,00011,2529,7073.90%-1,545
LONGBOARD PHARMACEUTICALS IN321,1540-321,1541,7860—-1,786
COMPASS THERAPEUTICS INC(CMPX)935,1570-935,1571,8420—-1,842
DESIGN THERAPEUTICS(DSGN)1,203,745280,000-923,7452,8417420.30%-2,099
OPTION CARE HEALTH(OPCH)220,000148,800-71,2007,1175,0132.01%-2,104
KEZAR LIFE SCIENCES4,770,7993,365,333-1,405,4665,6773,1881.28%-2,489
MIRUM PHARMACEUTICALS(MIRM)353,508293,301-60,20711,1718,6583.48%-2,513
DEXCOM(DXCM)62,42123,000-39,4215,8242,8541.15%-2,970
PENUMBRA INC(PEN)13,5000-13,5003,2660—-3,266
IRHYTHM TECHNOLOGIES INC(IRTC)35,0000-35,0003,2990—-3,299
MASIMO CORP40,0000-40,0003,5070—-3,507
BIOCRYST PHARMACEUTICALS(BCRX)2,408,1352,232,242-175,89317,05013,3715.37%-3,678
KURA ONCOLOGY(KURA)1,932,456950,000-982,45617,62413,6615.48%-3,963
NEUROCRINE BIOSCIENCES(NBIX)80,00035,900-44,1009,0004,7301.90%-4,270
TELADOC HEALTH INC(TDOC)250,0000-250,0004,6480—-4,647
CENTENE CORP DEL(CNC)80,0000-80,0005,5100—-5,510
NANOSTRING TECHNOLOGIES INC3,446,2740-3,446,2745,9280—-5,928
INSPIRE MED SYS INC(INSP)40,0000-40,0007,9380—-7,938
INARI MED INC130,0000-130,0008,5020—-8,502
PACIRA BIOSCIENCES(PCRX)1,210,377258,424-951,95337,1348,7193.50%-28,415
HUMANA INC(HUM)65,0000-65,00031,6240—-31,624
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q4 2023 | TickerTrail